Pharmamarketeer

Merck gets CHMP positive opinion for Rebif label amendment during pregnancy as clinically needed and while breastfeeding

Merck, a leading science and technology company, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion to update

Medhc-fases-banner
Advertentie(s)